← Back to Treatments
🏅 FDA Orphan Designation

Refluden

Lepirudin

Manufacturer: Hoechst Marion Roussel

Indicated for:
Classic heparin-induced thrombocytopeniaOrphan

FDA-Approved Indications (1)

For anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease in order to prevent further thromboembolic complications.

Indications & Usage

For anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease in order to prevent further thromboembolic complications.

💙 Support Programs

View all →
Refluden
Hoechst Marion Roussel
Refluden
Hoechst Marion Roussel

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.